ENO1-specific CD8+ T cell responses were detected in 8 out of 12 PDA patients with circulating anti-ENO1 IgG autoantibodies, whereas patients without these autoantibodies lacked these responses, suggesting an integrated humoral and cellular anti-ENO1 response (Cappello et al., 2009). This evidence concerns the gene ENO1 and Patent ductus arteriosus.